tiprankstipranks
Advertisement
Advertisement

APVO Stock Latest News

Aptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
The FlyAptevo Therapeutics reports FY25 EPS ($87.27) vs. ($31,460.23) last year
2d ago
APVO
Aptevo Therapeutics sees cash runway into 4Q26
PremiumThe Fly
Aptevo Therapeutics sees cash runway into 4Q26
2d ago
APVO
Aptevo Reports Promising Interim Data for AML Therapy
PremiumCompany Announcements
Aptevo Reports Promising Interim Data for AML Therapy
17d ago
8K
APVO
Aptevo Therapeutics announces interim data for mipletamig combination
PremiumThe Fly
Aptevo Therapeutics announces interim data for mipletamig combination
18d ago
APVO
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
PremiumCompany Announcements
Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity
1M ago
8K
APVO
Aptevo Therapeutics Announces CEO Transition and Leadership Changes
PremiumCompany AnnouncementsAptevo Therapeutics Announces CEO Transition and Leadership Changes
2M ago
8K
APVO
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
Premium
The Fly
Aptevo Therapeutics CEO Marvin White to retire, assume Executive Chair role
2M ago
APVO
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
Premium
The Fly
Aptevo Therapeutics files to sell 7.075M shares of common stock for holders
2M ago
APVO
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
PremiumCompany Announcements
Aptevo Therapeutics Secures $60 Million Equity Financing Facility
3M ago
8K
APVO
Aptevo Therapeutics secures $60M equity line of credit
PremiumThe Fly
Aptevo Therapeutics secures $60M equity line of credit
3M ago
APVO
Aptevo Therapeutics trading halted, news pending
PremiumThe Fly
Aptevo Therapeutics trading halted, news pending
3M ago
APVO
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split
PremiumCompany Announcements
Aptevo Therapeutics Implements 1-for-18 Reverse Stock Split
3M ago
8K
APVO
Upcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
PremiumMarket NewsUpcoming Stock Splits This Week (December 29 to January 2) – Stay Invested
3M ago
WOK
ACET
Aptevo Therapeutics Announces Promising RAINIER Trial Results
Premium
Company Announcements
Aptevo Therapeutics Announces Promising RAINIER Trial Results
4M ago
8K
APVO
Aptevo Therapeutics presents preliminary results from Phase 1b/2 RAINIER study
Premium
The Fly
Aptevo Therapeutics presents preliminary results from Phase 1b/2 RAINIER study
4M ago
APVO
Aptevo Therapeutics debuts trispecific antibody candidate APVO451
PremiumThe Fly
Aptevo Therapeutics debuts trispecific antibody candidate APVO451
5M ago
APVO
Aptevo Therapeutics management to meet virtually with Roth Capital
PremiumThe Fly
Aptevo Therapeutics management to meet virtually with Roth Capital
5M ago
APVO
Aptevo Therapeutics reports Q3 EPS ($2.23) vs. ($357.86) last year
PremiumThe Fly
Aptevo Therapeutics reports Q3 EPS ($2.23) vs. ($357.86) last year
5M ago
APVO
Aptevo Therapeutics sees cash runway into 4Q26
PremiumThe Fly
Aptevo Therapeutics sees cash runway into 4Q26
5M ago
APVO
Aptevo Therapeutics reports Q3 EPS (23c) vs. ($357.86) last year
PremiumThe FlyAptevo Therapeutics reports Q3 EPS (23c) vs. ($357.86) last year
5M ago
APVO
Aptevo’s Promising AML Study: A Potential Game-Changer for Investors
Premium
Company Announcements
Aptevo’s Promising AML Study: A Potential Game-Changer for Investors
5M ago
APVO
Aptevo Therapeutics files to sell 6.9M shares of common stock for holders
Premium
The Fly
Aptevo Therapeutics files to sell 6.9M shares of common stock for holders
6M ago
APVO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >